These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 24133451)

  • 21. β Adrenergic Receptor Kinase C-Terminal Peptide Gene-Therapy Improves β2-Adrenergic Receptor-Dependent Neoangiogenesis after Hindlimb Ischemia.
    Cannavo A; Liccardo D; Lymperopoulos A; Gambino G; D'Amico ML; Rengo F; Koch WJ; Leosco D; Ferrara N; Rengo G
    J Pharmacol Exp Ther; 2016 Feb; 356(2):503-13. PubMed ID: 26604244
    [TBL] [Abstract][Full Text] [Related]  

  • 22. G protein-coupled receptor kinase 2: a link between myocardial contractile function and cardiac metabolism.
    Woodall MC; Ciccarelli M; Woodall BP; Koch WJ
    Circ Res; 2014 May; 114(10):1661-70. PubMed ID: 24812353
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Blockade of β-adrenoceptors restores the GRK2-mediated adrenal α(2) -adrenoceptor-catecholamine production axis in heart failure.
    Rengo G; Lymperopoulos A; Zincarelli C; Femminella G; Liccardo D; Pagano G; de Lucia C; Cannavo A; Gargiulo P; Ferrara N; Perrone Filardi P; Koch W; Leosco D
    Br J Pharmacol; 2012 Aug; 166(8):2430-40. PubMed ID: 22519418
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Therapeutic Targets for Treatment of Heart Failure: Focus on GRKs and β-Arrestins Affecting βAR Signaling.
    Mangmool S; Parichatikanond W; Kurose H
    Front Pharmacol; 2018; 9():1336. PubMed ID: 30538631
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vivo inhibition of elevated myocardial beta-adrenergic receptor kinase activity in hybrid transgenic mice restores normal beta-adrenergic signaling and function.
    Akhter SA; Eckhart AD; Rockman HA; Shotwell K; Lefkowitz RJ; Koch WJ
    Circulation; 1999 Aug; 100(6):648-53. PubMed ID: 10441103
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dynamic regulation of phosphoinositide 3-kinase-gamma activity and beta-adrenergic receptor trafficking in end-stage human heart failure.
    Perrino C; Schroder JN; Lima B; Villamizar N; Nienaber JJ; Milano CA; Naga Prasad SV
    Circulation; 2007 Nov; 116(22):2571-9. PubMed ID: 17998459
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel roles for G protein-coupled receptor kinases in cardiac injury and repair.
    Kayki-Mutlu G; Koch WJ
    Biochem Soc Trans; 2023 Apr; 51(2):715-724. PubMed ID: 37013982
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeted inhibition of beta-adrenergic receptor kinase-1-associated phosphoinositide-3 kinase activity preserves beta-adrenergic receptor signaling and prolongs survival in heart failure induced by calsequestrin overexpression.
    Perrino C; Naga Prasad SV; Patel M; Wolf MJ; Rockman HA
    J Am Coll Cardiol; 2005 Jun; 45(11):1862-70. PubMed ID: 15936620
    [TBL] [Abstract][Full Text] [Related]  

  • 29. GRK2 in the heart: a GPCR kinase and beyond.
    Huang ZM; Gao E; Chuprun JK; Koch WJ
    Antioxid Redox Signal; 2014 Nov; 21(14):2032-43. PubMed ID: 24702056
    [TBL] [Abstract][Full Text] [Related]  

  • 30. G protein-coupled receptor kinase 2 activity impairs cardiac glucose uptake and promotes insulin resistance after myocardial ischemia.
    Ciccarelli M; Chuprun JK; Rengo G; Gao E; Wei Z; Peroutka RJ; Gold JI; Gumpert A; Chen M; Otis NJ; Dorn GW; Trimarco B; Iaccarino G; Koch WJ
    Circulation; 2011 May; 123(18):1953-62. PubMed ID: 21518983
    [TBL] [Abstract][Full Text] [Related]  

  • 31. G protein-coupled receptor kinase 2 contributes to impaired fatty acid metabolism in the failing heart.
    Pfleger J; Gross P; Johnson J; Carter RL; Gao E; Tilley DG; Houser SR; Koch WJ
    J Mol Cell Cardiol; 2018 Oct; 123():108-117. PubMed ID: 30171848
    [TBL] [Abstract][Full Text] [Related]  

  • 32. G protein-coupled receptor kinases in normal and failing myocardium.
    Huang ZM; Gold JI; Koch WJ
    Front Biosci (Landmark Ed); 2011 Jun; 16(8):3047-60. PubMed ID: 21622221
    [TBL] [Abstract][Full Text] [Related]  

  • 33. AAV6.βARKct cardiac gene therapy ameliorates cardiac function and normalizes the catecholaminergic axis in a clinically relevant large animal heart failure model.
    Raake PW; Schlegel P; Ksienzyk J; Reinkober J; Barthelmes J; Schinkel S; Pleger S; Mier W; Haberkorn U; Koch WJ; Katus HA; Most P; Müller OJ
    Eur Heart J; 2013 May; 34(19):1437-47. PubMed ID: 22261894
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeted beta-adrenergic receptor kinase (betaARK1) inhibition by gene transfer in failing human hearts.
    Williams ML; Hata JA; Schroder J; Rampersaud E; Petrofski J; Jakoi A; Milano CA; Koch WJ
    Circulation; 2004 Apr; 109(13):1590-3. PubMed ID: 15051637
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeted inhibition of phosphoinositide 3-kinase activity as a novel strategy to normalize beta-adrenergic receptor function in heart failure.
    Perrino C; Rockman HA; Chiariello M
    Vascul Pharmacol; 2006 Aug; 45(2):77-85. PubMed ID: 16807128
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Therapeutic potential of G-protein coupled receptor kinases in the heart.
    Iaccarino G; Koch WJ
    Expert Opin Investig Drugs; 1999 May; 8(5):545-54. PubMed ID: 15992114
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mdm2 regulates cardiac contractility by inhibiting GRK2-mediated desensitization of β-adrenergic receptor signaling.
    Jean-Charles PY; Yu SM; Abraham D; Kommaddi RP; Mao L; Strachan RT; Zhang ZS; Bowles DE; Brian L; Stiber JA; Jones SN; Koch WJ; Rockman HA; Shenoy SK
    JCI Insight; 2017 Sep; 2(17):. PubMed ID: 28878120
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of a beta-adrenergic receptor kinase 1 inhibitor prevents the development of myocardial failure in gene-targeted mice.
    Rockman HA; Chien KR; Choi DJ; Iaccarino G; Hunter JJ; Ross J; Lefkowitz RJ; Koch WJ
    Proc Natl Acad Sci U S A; 1998 Jun; 95(12):7000-5. PubMed ID: 9618528
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aldosterone Jeopardizes Myocardial Insulin and β-Adrenergic Receptor Signaling
    Cannavo A; Marzano F; Elia A; Liccardo D; Bencivenga L; Gambino G; Perna C; Rapacciuolo A; Cittadini A; Ferrara N; Paolocci N; Koch WJ; Rengo G
    Front Pharmacol; 2019; 10():888. PubMed ID: 31447681
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New Insights in Cardiac β-Adrenergic Signaling During Heart Failure and Aging.
    de Lucia C; Eguchi A; Koch WJ
    Front Pharmacol; 2018; 9():904. PubMed ID: 30147654
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.